Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress最新文献

筛选
英文 中文
Effect of dialysate buffer on potassium removal during haemodialysis. 透析液缓冲液对血液透析中钾去除的影响。
A J Williams, J N Barnes, J Cunningham, F J Goodwin, F P Marsh
{"title":"Effect of dialysate buffer on potassium removal during haemodialysis.","authors":"A J Williams,&nbsp;J N Barnes,&nbsp;J Cunningham,&nbsp;F J Goodwin,&nbsp;F P Marsh","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>There is a linear relationship between potassium removal during haemodialysis and plasma potassium (Kp). Kp falls rapidly during the first hour of dialysis but very little during the last two hours of a five hour dialysis. There is a fairly constant movement of potassium from the intracellular to extracellular space throughout dialysis. Total potassium removal is best predicted by pre-dialysis Kp, but change in Kp is related to the impact of dialysis on acid-base status. The choice of acetate or bicarbonate buffered dialysate does not effect potassium removal during dialysis.</p>","PeriodicalId":77886,"journal":{"name":"Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress","volume":"21 ","pages":"209-14"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14120909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human pancreatic polypeptide and somatostatin in chronic renal failure. 人胰多肽和生长抑素在慢性肾衰竭中的作用。
R Lugari, S David, P Dall'Argine, V Nicolotti, A Parmeggiani, A Gnudi, A Luciani, S Toscani, R Zandomeneghi
{"title":"Human pancreatic polypeptide and somatostatin in chronic renal failure.","authors":"R Lugari,&nbsp;S David,&nbsp;P Dall'Argine,&nbsp;V Nicolotti,&nbsp;A Parmeggiani,&nbsp;A Gnudi,&nbsp;A Luciani,&nbsp;S Toscani,&nbsp;R Zandomeneghi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Human pancreatic polypeptide is the only hormone so far reported which clearly suppresses somatostatin release, suggesting that this peptide may have a role in controlling somatostatin secretion from the gut and pancreas. In this study endogenous high circulating human pancreatic polypeptide concentrations in patients with chronic renal failure do not decrease somatostatin circulating levels. The reduced clearance rate of somatostatin in chronic renal failure may partially account for the normal circulating levels of somatostatin observed in our patients with respect to controls. Renal insufficiency may, itself, induce an increase in some gastrointestinal peptides capable of stimulating somatostatin secretion.</p>","PeriodicalId":77886,"journal":{"name":"Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress","volume":"21 ","pages":"614-7"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13996509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of cyclosporine only in cadaveric renal transplant recipients: conversion to prednisolone and azathioprine after four months. 仅在尸体肾移植受者中使用环孢素:4个月后改用泼尼松龙和硫唑嘌呤。
A M Tegzess, A J Donker, S Meijer, W J van Son, F J van Woude, M J Slooff, V J Fidler, W J Sluiter, L B van der Slikke
{"title":"The use of cyclosporine only in cadaveric renal transplant recipients: conversion to prednisolone and azathioprine after four months.","authors":"A M Tegzess,&nbsp;A J Donker,&nbsp;S Meijer,&nbsp;W J van Son,&nbsp;F J van Woude,&nbsp;M J Slooff,&nbsp;V J Fidler,&nbsp;W J Sluiter,&nbsp;L B van der Slikke","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>After conversion from cyclosporine (Cys) only to prednisolone and azathioprine four months after cadaveric renal transplantation, effective renal plasma flow (ERPF), glomerular filtration rate (GFR) and filtration fraction (FF) all improve. However, this improvement is not uniform. GFR and FF improve in all patients after one week of combined Cys and prednisolone treatment. ERPF improves under the same circumstances only in recipients without previous rejection episodes. After discontinuation of Cys and addition of azathioprine ERPF improves further in all patients. These findings suggest the presence of a low grade rejection, together with Cys nephrotoxicity. The conversion procedure seems to be safe at least during a follow-up period of 9-14 months.</p>","PeriodicalId":77886,"journal":{"name":"Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress","volume":"21 ","pages":"992-7"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15003931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Results of transplantation of kidneys from diabetic donors. 糖尿病供体肾脏移植的结果。
H van Goor, M J Slooff, G D Kremer, A M Tegzess
{"title":"Results of transplantation of kidneys from diabetic donors.","authors":"H van Goor,&nbsp;M J Slooff,&nbsp;G D Kremer,&nbsp;A M Tegzess","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Diabetic donors are still reluctantly accepted as potential organ donors because of supposed poor graft function caused by diabetic lesions. The results of transplantation of six kidneys from three donors with insulin dependent diabetes mellitus are reported. All three donors had a normal creatinine clearance and absence of proteinuria. Renal biopsies were taken. Five grafts are still functioning, six months to two years after transplantation with a mean creatinine clearance of 69ml/min (range 51-95). Three of five biopsies taken six months after transplantation showed marked decrease of the diabetic lesions. On the basis of these findings it seems justified to accept kidneys from diabetic donors for transplantation.</p>","PeriodicalId":77886,"journal":{"name":"Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress","volume":"21 ","pages":"655-8"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15003936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-invasive assessment of the kidney. What do nuclear medicine, ultrasonography, digital vascular imaging, computed tomography and magnetic resonance contribute to diagnosis in nephrology? 肾脏的无创评估。核医学、超声、数字血管成像、计算机断层扫描和磁共振对肾脏病诊断有何贡献?
C van Ypersele de Strihou
{"title":"Non-invasive assessment of the kidney. What do nuclear medicine, ultrasonography, digital vascular imaging, computed tomography and magnetic resonance contribute to diagnosis in nephrology?","authors":"C van Ypersele de Strihou","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77886,"journal":{"name":"Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress","volume":"21 ","pages":"771-90"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15003939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early protein restriction in chronic renal failure. 慢性肾衰竭的早期蛋白质限制。
J B Rosman, P M ter Wee, G P Piers-Becht, W J Sluiter, F J van der Woude, S Meijer, A J Donker
{"title":"Early protein restriction in chronic renal failure.","authors":"J B Rosman,&nbsp;P M ter Wee,&nbsp;G P Piers-Becht,&nbsp;W J Sluiter,&nbsp;F J van der Woude,&nbsp;S Meijer,&nbsp;A J Donker","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We performed a prospective randomised trial in 199 patients with various stages of renal failure. Stratified for sex, age and renal insufficiency, 105 patients were assigned to a protein (Pr)-restricted group (0.4-0.6g/kg/BW), and 94 to a control group. Pr-restriction led to a significant reduction in the excretion of urea, phosphate and protein. Survival of renal function was significantly better in Pr-restricted patients. Median serum creatinine concentration increased in the control group (p less than 0.05), but remained stable in Pr-restricted patients. We conclude that Pr-restriction retards, or even halts the progression of chronic renal failure.</p>","PeriodicalId":77886,"journal":{"name":"Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress","volume":"21 ","pages":"567-73"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15004105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Haemodialysis in dogs with a heparin coated hollow fibre dialyser. 肝素包覆中空纤维透析器在犬血液透析中的应用。
L E Lins, P Olsson, M B Hjelte, R Larsson, O Larm
{"title":"Haemodialysis in dogs with a heparin coated hollow fibre dialyser.","authors":"L E Lins,&nbsp;P Olsson,&nbsp;M B Hjelte,&nbsp;R Larsson,&nbsp;O Larm","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Haemodialysis was performed in non-uraemic dogs with equipment coated with a stable heparin. During a three hour dialysis a constant blood flow of 205 ml/min was easily maintained. There was no increase in whole blood coagulation time and no heparin release from the surface. The platelet count was initially reduced by 15 per cent, but remained constant at this value throughout the dialysis. No increase in FPA concentration was detected. Heparin coating on inherently thrombogenic materials enables haemodialysis in the absence of systemic anticoagulation and without measurable activation of the haemostatic mechanism.</p>","PeriodicalId":77886,"journal":{"name":"Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress","volume":"21 ","pages":"270-5"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15103691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low molecular weight heparin in haemodialysis and haemofiltration--comparison with unfractioned heparin. 低分子量肝素在血液透析和血液滤过中的应用——与未分离肝素的比较。
H Renaud, P Moriniere, J Dieval, Z Abdull-Massih, H Dkhissi, F Toutlemonde, J Delobel, A Fournier
{"title":"Low molecular weight heparin in haemodialysis and haemofiltration--comparison with unfractioned heparin.","authors":"H Renaud,&nbsp;P Moriniere,&nbsp;J Dieval,&nbsp;Z Abdull-Massih,&nbsp;H Dkhissi,&nbsp;F Toutlemonde,&nbsp;J Delobel,&nbsp;A Fournier","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The low molecular weight heparin CY 222 (CHOAY) has been compared to unfractioned heparin (UFH) in patients on chronic haemodialysis and haemofiltration at various doses as regards it biological activity (measured by Activated Partial Thromboplastin Time and by anti-Xa activity) and its clinical effect on clot formation in the blood lines and bleeding at the puncture sites or recent wounds. Compared to UFH, CY 222 has a greater anti-Xa activity for a shorter APTT. This biological difference is of clinical advantage since clotting in lines is comparable or less than with UFH whereas compression time at puncture sites is shorter and recently bleeding wounds in 28 patients did not bleed again. The long half life of CY 222 allows its use as a single priming dose of 300 anti-Xa U/kg in haemodialysis and 450 anti-Xa U/kg in haemofiltration.</p>","PeriodicalId":77886,"journal":{"name":"Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress","volume":"21 ","pages":"276-80"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15103692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platelet life span in uraemia. 尿毒症患者血小板寿命。
H Tanaka, K Umimoto, N Izumi, K Nishimoto, T Maekawa, T Kishimoto, M Maekawa
{"title":"Platelet life span in uraemia.","authors":"H Tanaka,&nbsp;K Umimoto,&nbsp;N Izumi,&nbsp;K Nishimoto,&nbsp;T Maekawa,&nbsp;T Kishimoto,&nbsp;M Maekawa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Platelet life span estimated by the regeneration time of platelet cyclo-oxygenase activity after acetyl salicylic acid (ASA) intake, as measured by the malonyldialdehyde (MDA) production rate was 10.3 +/- 1.0 days for healthy volunteers (n = 7), 6.7 +/- 1.0 days for haemodialysis patients (n = 13), 8.0 +/- 1.5 days for continuous ambulatory peritoneal dialysis (CAPD) patients (n = 6) and 5.0 and 4.9 days for non-dialysed uraemic patients (n = 2). In uraemic patients, the platelet cyclo-oxygenase activity was significantly impaired and it correlated with the decline in platelet life span. The restoration of the platelet life span and cyclooxygenase activity was achieved better by CAPD.</p>","PeriodicalId":77886,"journal":{"name":"Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress","volume":"21 ","pages":"306-10"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15103697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of acute and chronic ranitidine administration on renal function and parathyroid activity in chronic renal failure. 急性和慢性雷尼替丁对慢性肾功能衰竭患者肾功能和甲状旁腺活性的影响。
N Pozet, M Labeeuw, A Hadj Aissa, C Bizolon, P Zech, J Traeger
{"title":"Effects of acute and chronic ranitidine administration on renal function and parathyroid activity in chronic renal failure.","authors":"N Pozet,&nbsp;M Labeeuw,&nbsp;A Hadj Aissa,&nbsp;C Bizolon,&nbsp;P Zech,&nbsp;J Traeger","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In 11 patients with advanced renal failure, chronic treatment with ranitidine decreased plasma immunoreactive parathormone (PTH) without affecting phosphate reabsorption or urinary excretion of cyclic AMP. No significant changes in glomerular filtration rate and in urinary excretion of electrolytes were evident.</p>","PeriodicalId":77886,"journal":{"name":"Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress","volume":"21 ","pages":"761-4"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15103832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信